Dionymed Brands Stock (CSE: DYME) (OTC: DYMEF) - Investor Dashboard


Dionymed Brands
CSE Ticker: DYME
OTCQB Ticker: DYMEF
Sector: Medical/Adult-use
Industry: CPG
Country: Canada
Employees: 480 as of 05/31/19
Established: 2017
CEO: TBD

Summary

Fiscal Year-End: Dec 31
Auditor: MNP LLP
Exchanges: CSE, OTC
Trading Debut: 11/29/18
States of Operation: 4
Headquarters: Vancouver, BC

Financials (06/30/19)

Cash on hand: $1.6 million
Fixed Investment: $2.5 million
Shareholders’ Equity: -$6.7 million
Revenue: $9.0 million
Adj. Gross Margin : 17.7%
EPS : -$0.16

Capital Structure (08/28/19)

Last Financing: 3.8 million units at C$2.75
Basic Shares: 66.7 million
Warrants: 25.9 million
Options: 8.9 million
Diluted Shares: 106.2 million

 


Company Brief

Founded in 2017, DionyMed, also known as DYME Brands, is a rapidly-growing, multi-state cannabis brands and distribution platform, supporting cultivators, manufacturers and award-winning brands in the medical and adult-use cannabis markets. DionyMed entered the cannabis industry in the vape cartridge manufacturing category and following California’s adult-use legalization in January 2018, expanded from manufacturing into distribution.

DionyMed sells branded products in every category from flower to vape cartridges, concentrates and edibles. DionyMed serves more than 850 dispensaries and 45,000 Direct-To-Consumer deliveries each month with its growing portfolio of products and brands.


Highlights

  • Provides cannabis brand distribution to 900+ retail stores and 1500+ direct-to-consumer deliveries per day
  • Operating in California, Oregon, Nevada and Massachusetts with near-term plans to enter Colorado and Michigan
  • Brands, both proprietary and partner, range across all categories and price points
  • Unparalleled data insights

Growth Strategy

  • Geographic expansion: Southern California, Colorado and Michigan are pending
  • Advertising to drive direct-to-consumer retail
  • Introduction of new and differentiated products
  • Acquisition of strategic complementary companies
  • Partnering to pursue Canadian and European markets

Differentiators

  • Dual focus on distribution to retailers and directly to consumers through delivery
  • Superior supply chain, with partners for cultivation, manufacturing, packaging & compliance and testing
  • Less capital required than other cannabis operators

Institutional Analyst Coverage

BOBBY BURLESON
Canaccord Genuity

KYLE MCPHEE
Cormark Securities


Curated Stories & News


Visit DYME Brands
at www.dyme.com.

New Cannabis Ventures in partnership with due diligence platform 420Investor, is the definitive source for fact-based, data-driven, financial information and relevant company news for qualified publicly traded cannabis companies. NCV extracts and parses only the most important content. Information is provided “as is” and solely for informational purposes, not for trading or advice. Dionymed Brands is a client of NCV Media, LLC. Read our full disclaimer.